Asters has a formidable pharmaceuticals and healthcare practice, advising global and local manufacturers and suppliers of pharmaceuticals, biotechnology products, and medical devices on a broad spectrum of Ukrainian legal issues. The firm is particularly strong in antitrust and competition, frequently assisting clients with merger clearance, horizontal cooperation arrangements, pricing and distribution strategies, marketing practices, and unfair competition risks. Its deep expertise also makes it a go-to firm for sector-specific antitrust investigations. Recent work has included legal support on clinical trials, distribution agreements, and advising on public procurement regulations in the healthcare sector. The firm acts as a pro bono legal counsel to Charity Fund Tabletochki supporting various regulatory and advocacy initiatives in the healthcare sector. The advisory team is guided by the firm’s partners, namely Vadym Samoilenko (corporate), Igor Svechkar (competition) and Julia Semeniy (IP). In June 2025, Borys Tyshchenko (previously – legal and compliance head at Stada) joined the team as counsel and head of pharmaceuticals and healthcare industry group.
Baker McKenzie Kyiv provides comprehensive legal support to research-driven multinational pharmaceutical and medical device companies, with a strategic emphasis on high-value matters including complex transactions, tax, intellectual property, antitrust, and regulatory compliance. The firm is widely recognized for its strong track record in healthcare M&A, having played a key role in virtually all major healthcare deals in Ukraine. Most recently the firm advised the shareholders of Biopharma on post-closing and group restructuring matters, as well as associated tax ramifications, including the application of Controlled Foreign Companies rules to the post-closing structure and further potential investments. The firm is enlisted to advise on structuring distributor relationships in Ukraine in accordance with national healthcare, antitrust, and corporate regulations. Partner Viacheslav Yakymchuk is leading on M&A deals in the healthcare sector. Olha Sviatenka is the leading attorney within a larger multidisciplinary healthcare industry group in the Kyiv office, which consists of practitioners from other practice groups.
Ilyashev & Partners demonstrated a diverse and active presence in the pharmaceutical and healthcare sectors, providing legal support across regulatory, IP, public procurement, antitrust, and litigation matters. The firm represented JSC Kalceks in invalidating trademarks improperly used in pharmaceutical production by local companies. The firm also advised Chengdu Kanghong Biotechnology Co. Ltd on localizing clinical trial agreements and supported an international client in evaluating the legal framework for Direct-to-Patient services in clinical research. During the research period, the team was boosted with assignments for representation of both private individuals in high-profile medical disputes. The team achieved a favorable pre-trial settlement in a wrongful death case involving a leading private clinic, secured a conviction in a medical malpractice case following a three-year legal battle, and handled multiple patient rights cases before Ukraine’s health authorities and law-enforcement agencies. The firm also provides legal support for the inspection of the Shyriaivka Central District Hospital by the National Health Service of Ukraine. The firm’s clients include Dr. Reddy’s Laboratories, Macleods Pharmaceuticals, Takeda, Ukrainian Red Cross, Biopharma Plasma LLC. Alla Tsymanovska boosted her visibility with performance in high-profile medical cases. Yana Trynova, a doctor in law and an attorney specializing in criminal defense and medical malpractice cases, joined the team.
LA Law Firm (formerly Legal Alliance) maintained a robust focus on the life sciences sector, delivering strategic legal support to pharmaceutical and healthcare clients across Ukraine, Central and Eastern Europe, and Central Asia. The firm advised USAID’s SAFEMed project over the space of five years, playing a key role in shaping healthcare reforms, and provided legal counsel to an international initiative combating falsified medicines. The team supported the market entry of an innovative medical device (Stethophone), contributed to policy work on the Bolar exemption in Ukraine, and assisted a global pharmaceutical company in localizing production. Further notable work included regulatory support for a national pharmacy chain, legal assistance on access to medical services in war-affected regions, and multi-jurisdictional market expansion for a pharmaceutical company. The team’s expertise spans public procurement, pricing and reimbursement strategies, Health Technology Assessment, and regulatory frameworks for medicine import and distribution. Dmytro Aleshko, managing partner, possesses regulatory and policy-making expertise. Lidiia Sanzharovska, a seasoned legal professional, is another key team member. Antitrust and competition partner Andrii Gorbatenko is another renowned expert with many years of advisory practice in the sector.
AMBASSADORS, established in November 2023, is predominantly associated with the legacy of its founder Yaroslav Ognevyuk, a recognized expert in brand protection and IP enforcement. The team offers comprehensive support to pharmaceutical companies, combining deep litigation expertise with services spanning patent and trademark registration, IP transactions, portfolio management, and dispute resolution. The firm is particularly noted for representing pharmaceutical clients in complex patent disputes. For example, it represented Bayer AG in a landmark patent infringement case against Egis Pharmaceuticals PLC, arguing an attempt to register a generic version of Rivaroxaban.
Ante Law Firm possesses a solid pharmaceutical client roster across the pharmaceutical, medical devices, and healthcare sectors, and is known for its strong focus on regulatory compliance, IP protection, competition law, labor issues, and dispute resolution. Ante also stands out for its sector-specific antitrust expertise, frequently assisting clients with unfair competition cases and advertising compliance. During the research period the firm demonstrated a number of highlights: advising Egis on the application of the Bolar provision in Ukraine to support early-stage research for generic medicines; representing Sanofi Aventis in a dispute over unfair competition involving misuse of its brand name by a Ukrainian company; counseling Aristo Pharma Group and its subsidiary esparma Pharma Services on potential competitor violations and advertising compliance with competition law. The firm is also actively engaged for disputes work, recently assisting DK VET LLC in a veterinary pharmaceutical dispute and subsequent settlement. Another area of the firm’s expertise is the regulation of cannabis circulation for medical, industrial, and scientific purposes, where it advised Pharmway Trading on Ukrainian legislation. Managing partner Andriy Guck is highly visible on the market.
Doubinsky & Osharova, a leading Ukrainian IP boutique, is highly-regarded for its expertise in complex infringement disputes in the pharmaceutical and life sciences sectors, with a particular focus on representing originator drug manufacturers. During the period under research, the firm achieved notable success for Merck Sharp & Dohme LLC in a high-profile patent infringement case, securing a court ruling that prohibited the use and state registration of a generic medicinal product infringing Merck’s patented compounds. The team also prevailed in a trademark dispute by securing the invalidation of conflicting marks “НУТРІДЕМ” and “NutriDem”. Partner Victoria Sopilnyak guides clients from the pharmaceutical sector.
With its policy-driven expertise, EY Ukraine is involved in advising on large-scale healthcare reform projects in collaboration with international institutions. For example, being enlisted by the World Health Organization, the team provides legal support to codify the development cycle of Ukraine’s Program of Medical Guarantees (PMG), aiming to enhance governance, transparency, and accountability in the healthcare funding process. As part of a World Bank initiative, EY is leading a multidisciplinary consortium to design a comprehensive healthcare service delivery model for a major Ukrainian urban agglomeration, focusing on infrastructure, financing, and long-term systemic needs. The firm is, in partnership with UNDP, developing a conceptual model to assess and deliver integrated services — medical, social, educational, and employment — for people with disabilities, which includes legislative drafting and digitalization strategies. In addition, EY Ukraine also brings unique expertise in assessing and supporting public-private partnership (PPP) initiatives, exemplified by such notable projects as pre-feasibility assessments for healthcare PPPs in Lviv and Zhytomyr, as well as for the establishment of a Children’s Medical Rehabilitation Center in Ukraine. Bogdan Malniev, associate partner, is a team leader.
During the research period, Gramatskiy & Partners expanded its pharmaceutical and healthcare practice, handling complex mandates across regulatory compliance, licensing, IP protection, and commercial structuring. The firm advised Optima-Pharm Ltd on the comprehensive restructuring of its regional wholesale and distribution model, enabling successful expansion into new export markets; supported Pharmkhim LLC in launching a new pharmaceutical formulation, guiding cross-border certification, GMP production agreements, and pharmacovigilance compliance. In the area of regulatory enforcement, the team successfully defended Pharmacy Provizor Kyiv against unscheduled inspections, restoring its license and avoiding penalties. The firm continues to advise Cosmostar, a leading cosmetology chain, on the legal structuring of aesthetic medicine services and trademark portfolio expansion. The practice is supervised by Volodymyr Khomenko.
Kinstellar advises clients across the healthcare and life sciences sector on key regulatory and compliance matters in Ukraine. Its expertise covers clinical trial approvals, telemedicine and medical service licensing, import of medical devices in line with local technical regulations, etc. The team also provides legal support on competition matters, sector-related M&A, IP rights assignment. Among recent highlights is representing Intervet Agencies B.V. in Ukraine in a dispute which can potentially relate to the quality of the medicines produced by the client. The client list covers HealthJoy, PJSC Kyivstar, International Rescue Committee (IRC), Nobel Ilac Sanayii ve Ticaret A.S., Pfizer, Thermo Fisher Scientific Inc. The practice is co-led by partners Anastasiya Bolkhovitinova and Natalia Kirichenko.
Mamunya IP, a leading Ukrainian intellectual property boutique, is highly-regarded for its specialized pharmaceutical practice, representing major international innovative and generic drug manufacturers as well as Ukrainian patients’ organizations. The firm provides patent and trademark prosecution, IP enforcement and litigation, anti-counterfeiting measures, regulatory and advertising advice, and actions related to unfair competition and cancellation of marketing authorizations due to IP infringement. The firm continues to be involved in precedent-setting pharmaceutical IP litigation. During the period under research, the team won a landmark victory on behalf of a global pharmaceutical manufacturer in a long-anticipated case regarding supplementary protection certificates (SPCs). The firm is also handling a rare case in Ukraine involving patent law violations brought against the Ministry of Health. Disclosable clients include Synthon International Holding B.V., Jeunesse Global Holdings, CO 100% life. Founding partner Oleksandr Mamunya has a strong track record of success in high-stakes pharmaceutical patent litigation.
Mitrax is steadily expanding its footprint in the field of medical law, responding to growing demand for legal services related to medical negligence and patient rights. The firm offers a comprehensive range of services, including claims for both material and moral damages, legal support in filing complaints and lawsuits, preparation of court documentation, and legal consultations on complex medical matters. During the research period, the firm acted on behalf of private individuals pursuing compensation claims related to improper medical care, particularly in the fields of dentistry, incorrect diagnosis, plastic surgery, etc. A key figure in the practice is Yana Babenko, who leads this area with a strong focus on representing individual clients in sensitive and high-stakes cases.
Possessing a versatile international client base, INTEGRITES was entrusted with mandates from companies in the pharmaceutical and healthcare sectors, with the majority of assignments focused on corporate, employment, tax, litigation, and antitrust matters stemming from the imposition of martial law in Ukraine and the need to adapt business operations to wartime conditions. Most recently INTEGRITES advised Mécénat Servier on providing financial aid to the Ministry of Health of Ukraine through the UNITED24 platform, with the aim of financing the rebuilding of two hospitals located in Kyiv and Chernihiv Regions. The firm continues advising a long-standing client, Vamed Engineering GmbH, in three projects related to the design, (re)construction and (re)equipment of three healthcare facilities in Ukraine, including the Okhmatdyt National Children’s Specialized Hospital, a high-level children’s hospital in Kyiv. The sector related workload is led by a number of partners, namely Dr. Oleksiy Feliv (reconstruction), Illya Tkachuk (corporate and M&A), Viktoriya Fomenko (tax).
KM Partners offers niche expertise in transfer pricing and regulatory compliance within the pharmaceutical and healthcare sectors, with a strong focus on supporting both Ukrainian producers and international partners. During the research period, the team developed a tailored comparability adjustment methodology to address price regulation distortions on the Ukrainian pharmaceuticals market. The firm also advised a foreign company on the registration and implementation of international technical assistance projects in Ukraine, covering tax implications, currency restrictions, and compliance procedures, while providing guidance on engagement with public procurement authorities and reservation protocols. Partner Alexander Shemiatkin is the main point of contact.
Prikhodko & Partners provided full legal support in securing LKK certificates, establishing disability status (including for individuals residing abroad), accessing confidential medical records, and appealing unjustified refusals from healthcare institutions and commissions. Selected highlights for the research period include legal enforcement of patient rights to medical documentation, recognition of military-related disability for a discharged serviceman. Dariia Yeriomenko handles representation.
Our market research highlights law firms and professionals who, despite not submitting information for the current study, remain vivid market players and remain active in pharmaceuticals and healthcare practice in Ukraine. These highlights, sourced from public records, emphasize the firm’s market presence — a fact repeatedly validated via our in-depth interviews.[1]
AEQUO* is recognized for its strong capabilities in representing pharmaceutical and life sciences companies in complex trademark and patent litigation.
Arzinger*, as led by dedicated partner Lana Sinichkina, stands out as a prominent market player, widely recognized for its deep expertise in the pharmaceutical sector and an impressive client portfolio. Among its notable public highlights is the firm’s representation of Stada, a pharmaceutical company focused on manufacturing and distributing high-quality generics, in a precedent-setting dispute with the State Tax Administration.
Borys Danevych, partner and head of the life sciences and healthcare practices at CMS Cameron McKenna Nabarro Olswang*, is widely regarded for his deep expertise and well-established reputation in the sector.
Yuliia Duz, attorney at law at Helen Babich Law Office*, was mentioned by market participants for her visibility in medical cases.
[1] The firms marked with asterisk (*) have not submitted information for the current research.